March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.
Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.
Discover how Optical Coherence Tomography (OCT) technology can revolutionize the management of posterior segment diseases in this engaging editorial content by Dr. James L. Fanelli.
Ensure compliance and prompt payment by using proper ICD-10-CM codes for diagnosing patients with exudative age-related macular degeneration (wet AMD). Learn the guidelines for coding specific eye conditions and disease stages.
Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.
The FDA declined to approve Milestone’s etripamil nasal spray for PSVT, citing manufacturing issues and a need for more data on impurities, but raised no safety or efficacy concerns.